title: Identification of receptor ligands and receptor subtypes using antagonists in a capillary electrophoresis single-cell biosensor separation system.
abstract: A capillary electrophoresis system with single-cell biosensors as a detector has been used to separate and identify ligands in complex biological samples. The power of this procedure was significantly increased by introducing antagonists that inhibited the cellular response from selected ligand-receptor interactions. The single-cell biosensor was based on the ligand-receptor binding and G-protein-mediated signal transduction pathways in PC12 and NG108-15 cell lines. Receptor activation was measured as increases in cytosolic free calcium ion concentration by using fluorescence microscopy with the intracellular calcium ion indicator fluo-3-acetoxymethyl ester. Specifically, a mixture of bradykinin (BK) and acetylcholine (ACh) was fractionated and the components were identified by inhibiting the cellular response with icatibant (HOE 140), a selective antagonist to the BK B2 receptor subtype (B2BK), and atropine, an antagonist to muscarinic ACh receptor subtypes. Structurally related forms of BK were also identified based on inhibiting B2BK receptors. Applications of this technique include identification of endogenous BK in a lysate of human hepatocellular carcinoma cells (Hep G2) and screening for bioactivity of BK degradation products in human blood plasma. The data demonstrate that the use of antagonists with a single-cell biosensor separation system aids identification of separated components and receptor subtypes.
authors.affiliation: Department of Chemistry, Stanford University, CA 94305, USA.
authors.forename: H A
authors.initials: HA
authors.lastname: Fishman
authors.forename: O
authors.initials: O
authors.lastname: Orwar
authors.forename: R H
authors.initials: RH
authors.lastname: Scheller
authors.forename: R N
authors.initials: RN
authors.lastname: Zare
mesh_terms: D000818:Animals; D001285:Atropine / Q000494:pharmacology*; D001920:Bradykinin / Q000031:analogs & derivatives* / Q000032:analysis* / Q000494:pharmacology; D065168:Bradykinin Receptor Antagonists; D002197:Capillary Action; D006528:Carcinoma, Hepatocellular; D002460:Cell Line; D004586:Electrophoresis / Q000295:instrumentation / Q000379:methods*; D005910:Glioma; D006801:Humans; D008024:Ligands; D008113:Liver Neoplasms; D051379:Mice; D018727:Muscarinic Antagonists; D009447:Neuroblastoma; D016716:PC12 Cells; D051381:Rats; D018002:Receptors, Bradykinin / Q000032:analysis* / Q000145:classification; D011976:Receptors, Muscarinic / Q000032:analysis* / Q000145:classification; D014407:Tumor Cells, Cultured
chemical_list: D065168:Bradykinin Receptor Antagonists; D008024:Ligands; D018727:Muscarinic Antagonists; D018002:Receptors, Bradykinin; D011976:Receptors, Muscarinic; D001285:Atropine; C065679:icatibant; D001920:Bradykinin